Related Articles
Neoadjuvant chemotherapy with accelerated CNF plus G-CSF in patients with breast cancer tumors larger than three centimeters: a pilot study.
Accelerated neoadjuvant chemotherapy of non-small cell lung cancer (NSCLC)
The impact of schedule on acute toxicity and dose-intensity of high-dose chemotherapy with epirubicin and cyclophosphamide plus colony stimulating factors in advanced breast cancer.
COMBINATION CHEMOTHERAPY WITH CMF (CYCLOPHOSPHAMIDE, METHOTREXATE, 5-FLUOROURACIL) VERSUS CNF (MITOXANTRONE, 5-FLUOROURACIL, CYCLOPHOSPHAMIDE) IN ADVANCED BREAST-CANCER - A MULTICENTER RANDOMIZED STUDY
FEC (FLUOROURACIL, EPIRUBICIN, CYCLOPHOSPHAMIDE) PLUS GRANULOCYTE MACROPHAGE-COLONY-STIMULATING FACTOR (GM-CSF) IN ADVANCED OR INFLAMMATORY BREAST-CANCER - A DOSE-FINDING STUDY